Adjuvant chemotherapy in average-risk adult medulloblastoma patients improves survival: a long term study | BMC Cancer | Full Text

Adjuvant chemotherapy in average-risk adult medulloblastoma patients improves survival: a long term study | BMC Cancer | Full Text

Adjuvant chemotherapy in average-risk adult medulloblastoma patients improves survival: a long term study

Medulloblastoma is extremely rare in adults. The role of chemotherapy for average-risk adult patients remains controversial. Surgery and radiotherapy provide a significant disease control and a good prognosis,...

Authors:E. Franceschi, S. Minichillo, A. Mura, A. Tosoni, M. Mascarin, C. Tomasello, S. Bartolini and A. A. Brandes

Citation:BMC Cancer 2020 20:755

Content type:Research article

 

Published on: 12 August 2020

• ViewFull Text
 
• ViewPDF